Osaic Holdings
AVEO

Osaic Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Osaic Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-566
Closed -$9K – 7723
2022
Q4 		$9K Sell
566
-1,070
-65% -$14.8K ﹤0.01% 6025
2022
Q3 		$13K Buy
1,636
+71
+5% +$545 ﹤0.01% 5898
2022
Q2 		$10K Sell
1,565
-625
-29% -$3.03K ﹤0.01% 6141
2022
Q1 		$12K Sell
2,190
-245
-10% -$1.01K ﹤0.01% 6054
2021
Q4 		$11K Buy
2,435
+820
+51% +$5.09K ﹤0.01% 6226
2021
Q3 		$11K Sell
1,615
-25
-2% -$150 ﹤0.01% 6172
2021
Q2 		$11K Sell
1,640
-264
-14% -$1.82K ﹤0.01% 6039
2021
Q1 		$14K Buy
1,904
+684
+56% +$5.9K ﹤0.01% 5730
2020
Q4 		$7K Buy
1,220
+890
+270% +$5.09K ﹤0.01% 5690
2020
Q3 		$2K Sell
330
-100
-23% -$495 ﹤0.01% 5948
2020
Q2 		$2K Hold
430
– – ﹤0.01% 5879
2020
Q1 		$2K Buy
+430
New +$2.13K ﹤0.01% 5775

Osaic Holdings's AVEO Position: Q1 2023 in Review

Osaic Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 566 shares — an estimated $9K sold.

Osaic Holdings first reported a position in AVEO in Q1 2020 and held it in 12 quarters. The position peaked at $14K in Q1 2021. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Osaic Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 566 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $9K.
  • Osaic Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2020 and held it in 12 quarters.
  • Osaic Holdings's AVEO Pharmaceuticals, Inc. position peaked at $14K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.